|
Basic reproduction number |
2.8 |
(Deng et al., 2020, Linka et al., 2020, Wu et al., 2020, You et al., 2020) |
|
Transmission rate |
0.50 |
Estimated from
|
|
Social distancing level |
control |
Derived from optimization |
|
Probability that pre-symptomatic individuals will be tested and isolated |
control |
Derived from optimization |
|
Length of latent period (days) |
3.1 |
(Lauer et al., 2020) |
|
Length of pre-symptomatic infectious period (days) |
2 |
(Wei et al., 2020) |
|
Proportion of severely infectious individuals who are hospitalized |
0.2 |
(WHO, 2020b) |
|
Infectious period of mild infections (days) |
7 |
(Zhou et al., 2020) |
|
Average time in isolation of mildly infectious individuals (days) |
10 |
(CDC, 2020a) |
|
Average duration of hospitalization of severely infectious individuals (days) |
14.5 |
(Fonfría et al., 2020) |
|
Average duration from the onset of symptoms to diagnosis among infectious individuals with none-to-mild symptoms (days) |
4 |
(Burrer et al., 2020) |
|
Average duration from the onset of symptoms to diagnosis among infectious individuals with severe symptoms (days) |
4 |
(Burrer et al., 2020) |
|
Effectiveness of hospitalization and isolation in terms of preventing further transmission |
0.9 |
Assumed |
|
Average number of tests required to identify one infectious individual |
10 |
(CDC) |
|
Cost of social distancing (USD) |
178 |
(WorldBank, 2020) |
|
Cost of diagnostic test for COVID-19 (USD) |
142 |
(Nisha Kurani et al., 2020) |
|
Cost to treat a hospitalized patient with COVID-19 (USD) |
25,617 |
(Chen et al., 2020) |
|
Cost of treatment for individuals with mild COVID-19 infection (USD) |
3,045 |
(Bartsch et al., 2020) |
|
Upper bound of social distancing level |
0.5 |
Assumed |
|
Upper bound of testing intensity |
0.2 |
Assumed |